Deutsche Bank’s Dicerna Pharmaceuticals, Inc. DRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-49,026
| Closed | -$988K | – | 4490 |
|
|
2021
Q3 | $988K | Sell |
49,026
-87,569
| -64% | -$2.42M | ﹤0.01% | 2619 |
|
|
2021
Q2 | $5.1M | Buy |
136,595
+85,942
| +170% | +$2.63M | ﹤0.01% | 1511 |
|
|
2021
Q1 | $1.3M | Sell |
50,653
-4,005
| -7% | -$102K | ﹤0.01% | 2504 |
|
|
2020
Q4 | $1.2M | Buy |
54,658
+13,936
| +34% | +$307K | ﹤0.01% | 2323 |
|
|
2020
Q3 | $733K | Buy |
40,722
+2,906
| +8% | +$60.2K | ﹤0.01% | 2400 |
|
|
2020
Q2 | $960K | Buy |
37,816
+17,648
| +88% | +$380K | ﹤0.01% | 2253 |
|
|
2020
Q1 | $370K | Sell |
20,168
-33,866
| -63% | -$658K | ﹤0.01% | 2634 |
|
|
2019
Q4 | $1.19M | Sell |
54,034
-452,600
| -89% | -$9.11M | ﹤0.01% | 2272 |
|
|
2019
Q3 | $7.27M | Sell |
506,634
-44,891
| -8% | -$642K | 0.01% | 1202 |
|
|
2019
Q2 | $8.68M | Buy |
551,525
+24,268
| +5% | +$330K | 0.01% | 1455 |
|
|
2019
Q1 | $7.72M | Buy |
527,257
+21,951
| +4% | +$252K | ﹤0.01% | 1553 |
|
|
2018
Q4 | $5.4M | Buy |
505,306
+140,399
| +38% | +$1.85M | ﹤0.01% | 1719 |
|
|
2018
Q3 | $5.57M | Sell |
364,907
-21,641
| -6% | -$315K | ﹤0.01% | 2101 |
|
|
2018
Q2 | $4.74M | Buy |
386,548
+384,348
| +17,470% | +$4.83M | ﹤0.01% | 2341 |
|
|
2018
Q1 | $21K | Sell |
2,200
-166,200
| -99% | -$1.79M | ﹤0.01% | 4986 |
|
|
2017
Q4 | $1.52M | Buy |
168,400
+116,719
| +226% | +$859K | ﹤0.01% | 2921 |
|
|
2017
Q3 | $297K | Buy |
+51,681
| New | +$188K | ﹤0.01% | 3679 |
|
|
2017
Q2 | – | Sell |
-18,500
| Closed | -$62K | – | 5198 |
|
|
2017
Q1 | $62K | Sell |
18,500
-22,550
| -55% | -$63.5K | ﹤0.01% | 4142 |
|
|
2016
Q4 | $118K | Buy |
41,050
+20,413
| +99% | +$72.6K | ﹤0.01% | 3988 |
|
|
2016
Q3 | $121K | Sell |
20,637
-48,281
| -70% | -$169K | ﹤0.01% | 3876 |
|
|
2016
Q2 | $206K | Buy |
68,918
+12,127
| +21% | +$49.8K | ﹤0.01% | 3760 |
|
|
2016
Q1 | $302K | Buy |
56,791
+15,193
| +37% | +$95.9K | ﹤0.01% | 3469 |
|
|
2015
Q4 | $493K | Sell |
41,598
-15,366
| -27% | -$176K | ﹤0.01% | 3280 |
|
|
2015
Q3 | $467K | Buy |
56,964
+1,895
| +3% | +$21.9K | ﹤0.01% | 3392 |
|
|
2015
Q2 | $767K | Buy |
55,069
+55,060
| +611,778% | +$1.01M | ﹤0.01% | 3136 |
|
|
2015
Q1 | $0 | Buy |
9
+7
| +350% | +$157 | ﹤0.01% | 6166 |
|
|
2014
Q4 | $0 | Sell |
2
-12,245
| -100% | -$141K | ﹤0.01% | 6389 |
|
|
2014
Q3 | $155K | Buy |
12,247
+11,257
| +1,137% | +$170K | ﹤0.01% | 4238 |
|
|
2014
Q2 | $22K | Sell |
990
-12,168
| -92% | -$221K | ﹤0.01% | 5292 |
|
|
2014
Q1 | $371K | Buy |
+13,158
| New | +$489K | ﹤0.01% | 3519 |
|
Other funds holding DRNA
Deutsche Bank's DRNA Position: Q4 2021 in Review
Deutsche Bank sold out of Dicerna Pharmaceuticals, Inc. (DRNA) in Q4 2021, closing a stake of 49,026 shares — an estimated $988K sold.
Deutsche Bank first reported a position in DRNA in Q1 2014 and held it in 30 quarters. The position peaked at $8.68M in Q2 2019. 1 fund tracked by Wall St. Rank holds DRNA as of Q4 2021.
- Deutsche Bank reported no remaining Dicerna Pharmaceuticals, Inc. position as of Q4 2021 after selling out during the quarter.
- Deutsche Bank sold 49,026 Dicerna Pharmaceuticals, Inc. shares in Q4 2021, an estimated $988K.
- Deutsche Bank first reported a position in Dicerna Pharmaceuticals, Inc. in Q1 2014 and held it in 30 quarters.
- Deutsche Bank's Dicerna Pharmaceuticals, Inc. position peaked at $8.68M in Q2 2019.
- 1 fund tracked by Wall St. Rank held Dicerna Pharmaceuticals, Inc. as of Q4 2021.
Based on Deutsche Bank's 13F filing for Q4 2021, filed 11 Feb 2022.